10 recruiting. 10 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 10 |
| Phase 3 | 3 | Recruiting 3 |
| Phase 1 | 2 | Recruiting 2 |
Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy Tadalafil 5 mg, Pelvic Floor Muscle Training (PFMT), Aerobic Exercise Program - Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer | Phase 2 | Recruiting | Surgical Outcomes Research Centre (SOuRCe) | 64 | 2026-08-31 | 2026-10-23 |
| Stem Cells for Erectile Dysfunction Post RALP Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office, Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR, Placebo in the OR - Erectile Dysfunction, Prostate Cancer | Phase 1 / Phase 2 | Recruiting | The Methodist Hospital Research Institute | 40 | 2026-07-07 | 2026-07-10 |
| A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile Dysfunction ST-04 - Erectile Dysfunction (ED), Erectile Dysfunctions | Phase 2 | Recruiting | Ryan Flannigan, MD | 83 | 2026-05-01 | 2026-05-22 |
| TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Pitavastatin 1-4 mg daily, Rosuvastatin 20-40 mg daily - Erectile Dysfunction Due to Arterial Disease, Atheroscleroses | Phase 2 | Recruiting | Lomonosov Moscow State University Medical Research and Educational Center | 150 | 2026-03-05 | 2026-03-16 |
| Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction YN001 20mg Dose + 5% glucose injection, 5% glucose injection - Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction | Phase 2 | Recruiting | Beijing Inno Medicine Co., Ltd. | 40 | 2026-02-04 | 2026-09-22 |
| Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction Umbilical Cord-Derived Mesenchymal Stem Cells, Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes, Placebo Intracavernosal Injection - Erectile Dysfunction With Diabetes Mellitus | Phase 2 / Phase 3 | Recruiting | Ankara City Hospital Bilkent | 90 | 2025-12-29 | 2026-03-18 |
| Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients Tadalafil 5mg, BZ371A, Oral Placebo - Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction | Phase 2 | Recruiting | Biozeus Biopharmaceutical S.A. | 72 | 2023-11-22 | 2024-10-22 |
| Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate Tadalafil 5mg / Placebo - Erectile Dysfunction, Lower Urinary Tract Symptoms | Phase 2 / Phase 3 | Recruiting | Mansoura University | 110 | 2023-04-01 | 2025-06-11 |
| 4-aminopyridine Treatment for Nerve Injury 4-Aminopyridine, Placebo - Nerve Injury, Prostate Cancer | Phase 2 / Phase 3 | Recruiting | John Elfar | 70 | 2021-06-05 | 2025-12-17 |
| Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions PrimePro™/ PrimeMSK™ - Autoimmune Diseases, Cardiovascular Disorders | Phase 1 / Phase 2 | Recruiting | Thomas Advanced Medical LLC | 5000 | 2020-07-09 | 2022-04-29 |
Prostatic Neoplasms (4) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Alzheimer Disease (1) · Autoimmune Diseases (1) · Brain Diseases (1) · COVID-19 (1) · Cardiomyopathies (1) · Central Nervous System Diseases (1) · Coronary Artery Disease (1) · Dementia (1) · Diabetes Complications (1) · Disease (1) · Heart Diseases (1)
Genital Diseases (10) · Genital Diseases, Male (10) · Male Urogenital Diseases (10) · Sexual Dysfunctions, Psychological (10) · Urogenital Diseases (10) · Mental Disorders (9) · Sexual Dysfunction, Physiological (9) · Genital Neoplasms, Male (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Neoplasms (4) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2)
Tadalafil (3) · 4-Aminopyridine (1) · Ambulatory Care Facilities (1) · Glucose (1) · Rosuvastatin Calcium (1) · Saline Solution (1) · Sodium Chloride (1) · pitavastatin (1)
Ankara City Hospital Bilkent (1) · Beijing Inno Medicine Co., Ltd. (1) · Biozeus Biopharmaceutical S.A. (1) · John Elfar (1) · Lomonosov Moscow State University Medical Research and Educational Center (1) · Mansoura University (1) · Ryan Flannigan, MD (1) · Surgical Outcomes Research Centre (SOuRCe) (1) · The Methodist Hospital Research Institute (1) · Thomas Advanced Medical LLC (1)
United States (3) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Egypt (1) · Russia (1) · Turkey (Türkiye) (1)
Daniel Steffens (1) · Erkan Olcucuoglu, MD, Associate Professor (1) · Ernst R Von Schwarz, MD, PhD (1) · John Elfar, MD (1) · Mahmoud Laymon, MD,MRCS (1) · Rashid Sayyid, MD (1) · Samet Senel, MD, Associate Professor (1)